{"transactions":[{"id":1439569,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":88462,"kind":"organization","name":"Camber Capital Management LP","position":1,"cik":"0001444043","reported_name":"Camber Capital Management LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-08-06T16:15:22.000Z","date":"2024-08-02","kind":"sale","planned":false,"acquired":false,"shares":525000,"price":17.7131,"value":9299377.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities reported herein for Camber Capital Management LP (the \"LP\" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the \"Master Fund\")   for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the \"Reporting Persons\") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Of the securities reported for this transaction, 525,000 shares of Common Stock were sold for the account of the Master Fund"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"As of the closing of trading on August 02, 2024, 2,725,000 shares of Common Stock were held for the account of the Master Fund"}],"balance_after":2725000,"source":{"system":"sec-edgar","filing":"0001654954-24-010034","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444043/000165495424010034/section16.xml","form_type":"4"}},{"id":3014560,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":88462,"kind":"organization","name":"Camber Capital Management LP","position":1,"cik":"0001444043","reported_name":"Camber Capital Management LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2020-10-05T11:21:13.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":4390000,"price":13.5733,"value":59586787.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities reported herein for Camber Capital Management LP (the \"LP\" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the \"Master Fund\") and another private investment fund (the \"Fund\")  for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the \"Reporting Persons\") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Of the securities reported for this transaction, 4,361,316 shares of Common Stock were sold for the account of the Master Fund and 28,684 shares of Common Stock were sold for the account of the Fund"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"As of the closing of trading on October 01, 2020, 0 shares of Common Stock were held for the account of the Master Fund and 0 shares of Common Stock were held for the account of the Fund."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001654954-20-010821","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000165495420010821/section16.xml","form_type":"4"}},{"id":3442930,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":88462,"kind":"organization","name":"Camber Capital Management LP","position":1,"cik":"0001444043","reported_name":"Camber Capital Management LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-08-09T15:41:20.000Z","date":"2019-08-09","kind":"purchase","acquired":true,"shares":3400,"price":9.1781,"value":31205.54,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities reported herein for Camber Capital Management LP (the \"LP\" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the \"Master Fund\") and another private investment fund (the \"Fund\")  for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the \"Reporting Persons\") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Of the securities reported for this transaction, 3,378 shares of Common Stock were purchased for the account of the Master Fund and 22 shares of Common Stock were purchased for the account of the Fund"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"As of the closing of trading on August 09, 2019, 4,361,316 shares of Common Stock were held for the account of the Master Fund and 28,684 shares of Common Stock were held for the account of the Fund."}],"balance_after":4390000,"source":{"system":"sec-edgar","filing":"0001654954-19-009162","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/section16.xml","form_type":"4"}},{"id":3442929,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":88462,"kind":"organization","name":"Camber Capital Management LP","position":1,"cik":"0001444043","reported_name":"Camber Capital Management LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-08-09T15:41:20.000Z","date":"2019-08-09","kind":"purchase","acquired":true,"shares":26600,"price":8.9395,"value":237790.7,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities reported herein for Camber Capital Management LP (the \"LP\" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the \"Master Fund\") and another private investment fund (the \"Fund\")  for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the \"Reporting Persons\") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Of the securities reported for this transaction, 26,430 shares of Common Stock were purchased for the account of the Master Fund and 170 shares of Common Stock were purchased for the account of the Fund"}],"balance_after":4386600,"source":{"system":"sec-edgar","filing":"0001654954-19-009162","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/section16.xml","form_type":"4"}},{"id":3442928,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":88462,"kind":"organization","name":"Camber Capital Management LP","position":1,"cik":"0001444043","reported_name":"Camber Capital Management LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-08-09T15:41:20.000Z","date":"2019-08-07","kind":"purchase","acquired":true,"shares":4000,"price":7.575,"value":30300.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities reported herein for Camber Capital Management LP (the \"LP\" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the \"Master Fund\") and another private investment fund (the \"Fund\")  for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the \"Reporting Persons\") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Of the securities reported for this transaction, 3,974 shares of Common Stock were purchased for the account of the Master Fund and 26 shares of Common Stock were purchased for the account of the Fund"}],"balance_after":4360000,"source":{"system":"sec-edgar","filing":"0001654954-19-009162","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/section16.xml","form_type":"4"}},{"id":3442927,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":88462,"kind":"organization","name":"Camber Capital Management LP","position":1,"cik":"0001444043","reported_name":"Camber Capital Management LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-08-09T15:41:20.000Z","date":"2019-08-07","kind":"purchase","acquired":true,"shares":50000,"price":7.74,"value":387000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities reported herein for Camber Capital Management LP (the \"LP\" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the \"Master Fund\") and another private investment fund (the \"Fund\")  for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the \"Reporting Persons\") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Of the securities reported for this transaction, 49,680 shares of Common Stock were purchased for the account of the Master Fund and 320 shares of Common Stock were purchased for the account of the Fund"}],"balance_after":4356000,"source":{"system":"sec-edgar","filing":"0001654954-19-009162","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/section16.xml","form_type":"4"}},{"id":3442926,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":88462,"kind":"organization","name":"Camber Capital Management LP","position":1,"cik":"0001444043","reported_name":"Camber Capital Management LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-08-09T15:41:20.000Z","date":"2019-08-07","kind":"purchase","acquired":true,"shares":301000,"price":7.7857,"value":2343495.7,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities reported herein for Camber Capital Management LP (the \"LP\" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the \"Master Fund\") and another private investment fund (the \"Fund\")  for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the \"Reporting Persons\") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Of the securities reported for this transaction, 299,074 shares of Common Stock were purchased for the account of the Master Fund and 1,926 shares of Common Stock were purchased for the account of the Fund"}],"balance_after":4306000,"source":{"system":"sec-edgar","filing":"0001654954-19-009162","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/section16.xml","form_type":"4"}},{"id":4531992,"issuer":{"id":2671,"kind":"organization","name":"Protalix BioTherapeutics, Inc.","symbol":"PLX"},"owners":[{"id":88462,"kind":"organization","name":"Camber Capital Management LP","position":1,"cik":"0001444043","reported_name":"Camber Capital Management LLC","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2016-12-06T20:26:01.000Z","date":"2016-12-02","kind":"sale","acquired":false,"shares":2500000,"price":0.3168,"value":792000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities reported herein for Camber Capital Management LLC (the \"LLC\" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the \"Master Fund\"), another private investment fund (the \"Fund\") and one managed account (the \"Managed Account\") for which the LLC serves as the investment manager. Stephen DuBois is the managing member of the LLC and managing member of the general partner for the Fund and the Master Fund. The LLC, the Master Fund, the Fund, the Managed Account, general partner and Mr. DuBois (the \"Reporting Persons\") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Of the securities reported for this transaction, 2,413,466 shares of Common Stock were sold for the account of the Master Fund, 16,998 shares of Common Stock were sold for the account of the Fund, and 69,536 shares of Common Stock were sold for the account of the Managed Account."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"As of the closing of trading on December 06, 2016, 10,402,037 shares of Common Stock were held for the account of the Master Fund, 73,262 shares of Common Stock were held for the account of the Fund, and 299,701 shares of Common Stock were held for the account of the Managed Account."}],"balance_after":10775000,"source":{"system":"sec-edgar","filing":"0001354488-16-008627","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006281/000135448816008627/issuerdirect_section16.xml","form_type":"4"}},{"id":4598003,"issuer":{"id":114141,"kind":"organization","name":"Cardiovascular Systems Inc","symbol":"CSII"},"owners":[{"id":88462,"kind":"organization","name":"Camber Capital Management LP","position":1,"cik":"0001444043","reported_name":"Camber Capital Management LLC","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2016-09-21T12:28:45.000Z","date":"2016-09-20","kind":"sale","acquired":false,"shares":57000,"price":23.5376,"value":1341643.2,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities reported herein for Camber Capital Management LLC (the \"LLC\" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the \"Master Fund\"), another private investment fund (the \"Fund\") and one managed account (the \"Managed Account\") for which the LLC serves as the investment manager. Stephen DuBois is the managing member of the LLC and managing member of the general partner for the Fund and the Master Fund. The LLC, the Master Fund, the Fund, the Managed Account, general partner and Mr. DuBois (the \"Reporting Persons\") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Of the securities reported for this transaction, 55,331 shares of Common Stock were sold for the account of the Master Fund, 353 shares of Common Stock were sold for the account of the Fund, and 1,316 shares of Common Stock were sold for the account of the Managed Account."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"As of the closing of trading on September 20, 2016, 2,912,165 shares of Common Stock were held for the account of the Master Fund, 18,559 shares of Common Stock were held for the account of the Fund, and 69,276 shares of Common Stock were held for the account of the Managed Account."}],"balance_after":3000000,"source":{"system":"sec-edgar","filing":"0001354488-16-008291","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180145/000135448816008291/issuerdirect_section16.xml","form_type":"4"}},{"id":4598002,"issuer":{"id":114141,"kind":"organization","name":"Cardiovascular Systems Inc","symbol":"CSII"},"owners":[{"id":88462,"kind":"organization","name":"Camber Capital Management LP","position":1,"cik":"0001444043","reported_name":"Camber Capital Management LLC","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2016-09-21T12:28:45.000Z","date":"2016-09-19","kind":"sale","acquired":false,"shares":1043000,"price":23.2501,"value":24249854.3,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities reported herein for Camber Capital Management LLC (the \"LLC\" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the \"Master Fund\"), another private investment fund (the \"Fund\") and one managed account (the \"Managed Account\") for which the LLC serves as the investment manager. Stephen DuBois is the managing member of the LLC and managing member of the general partner for the Fund and the Master Fund. The LLC, the Master Fund, the Fund, the Managed Account, general partner and Mr. DuBois (the \"Reporting Persons\") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Of the securities reported for this transaction, 1,012,462 shares of Common Stock were sold for the account of the Master Fund, 6,453 shares of Common Stock were sold for the account of the Fund, and 24,085 shares of Common Stock were sold for the account of the Managed Account."}],"balance_after":3057000,"source":{"system":"sec-edgar","filing":"0001354488-16-008291","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180145/000135448816008291/issuerdirect_section16.xml","form_type":"4"}}]}